×

Compositions and methods for treating macular degeneration

  • US 8,877,809 B2
  • Filed: 09/12/2008
  • Issued: 11/04/2014
  • Est. Priority Date: 09/12/2007
  • Status: Expired
First Claim
Patent Images

1. A method of retarding the accumulation of a lipofuscin pigment in a retina, comprising administering an effective amount of a pharmaceutical composition to a patient in need thereof, wherein the pharmaceutical composition comprises a substituted C20-D1-3-retinoid, wherein the C20-D1-3-retinoid is selected from the group consisting of C20-D1-3-retinol C20-D1-3-retinol ester, C20-D1-3-retinal and C20-D1-3-pro-vitamin A carotenoids, and a pharmaceutically acceptable carrier.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×